<- Go home

Added to YB: 2024-12-18

Pitch date: 2024-12-17

HIMS [bullish]

Hims & Hers Health, Inc.

+18.73%

current return

Author Info

No bio for this author

Company Info

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, and internationally.

Market Cap

$8.9B

Pitch Price

$31.34

Price Target

42.00 (+13%)

Dividend

N/A

EV/EBITDA

52.94

P/E

73.02

EV/Sales

4.26

Sector

Health Care Providers and Services

Category

growth

Show full summary:
Hims & Hers (HIMS): Morgan Stanley Sets $42 Target Amid Strong Growth Projections

HIMS: Morgan Stanley initiates Overweight, $42 PT. 30% rev CAGR 2024-26, 80% GM. Strong mgmt from Uber, Netflix, FDA. Personalization driving 175% y/y subscriber growth. PT based on 3.5x CY26 EV/S, 24x EV/EBITDA. Bull/Bear case skew 2.5:1. Estimates 5%/9% above Street for 2025 rev/EBITDA.

Read full article (1 min)